References
- Palumbo A, Facon T, Sonneveld P, et al Thalidomide for treatment of multiple myeloma: 10 years later. Blood 2008;111:3968–3977.
- Ghobrial IM, Rajkumar SV. Management of thalidomide toxicity. J Support Oncol 2003;1:194–205.
- Gilliland P, Holguin M. Phrenic nerve paralysis due to vincristine. Leuk Lymphoma 2007;48:2452–2453.
- Sandham JD, Shaw DT, Buenter CA. Acute supine respiratory failure due to bilateral diaphragmatic paralysis. Chest 1977;72:96–98.
- Kumar N, Folger WN, Bolton CF. Dyspnea as the predominant manifestation of bilateral phrenic neuropathy. Mayo Clin Proc 2004;79:1563–1565.
- Stowasser M, Cameron J, Oliver WA. Diaphragmatic paralysis following cervical herpes zoster. Med J Aust 1990;153:555–556.
- Imai T, Matsumoto H. Insidious phrenic nerve involvement in postpolio syndrome. Intern Med 2006;45:563–564.
- Janda A. Neurological complications secondary to subclavian venipuncture. Anesthesist 1981;30:148–149.
- Balbierz JM, Ellenberg M, Honet JC. Complete hemidiaphragmatic paralysis in a patient with multiple sclerosis. Am J Phys Med Rehabil 1988;67:161–165.
- Tang EW, Jardine DL, Rodins K, Evans J. Respiratory failure secondary to diabetic neuropathy affecting the phrenic nerve. Diabet Med 2003;20:599–601.
- Mileshkin L, Stark R, Day B, et al Development of neuropathy in patients with myeloma treated with thalidomide: patterns of occurrence and the role of electrophysiologic monitoring. J Clin Oncol 2006;24:4507–4514.
- Cavaletti G, Beronio A, Reni L, et al Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study. Neurology 2004;62:2291.